Zdrowie i gospodarka · 05/10/2010
FDA Clears AZDONE for Approval After Safety Review
The FDA has determined that AZDONE, a hydrocodone and aspirin tablet, was not withdrawn from sale due to safety concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Health and Human ServicesOpen original release →